Titan Pharmaceuticals Stock Price - TTNP

0.36
0.00 (0.0%)
0.36
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Titan Pharmaceuticals Inc TTNP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0885 32.6% 0.36 0.2857 0.379 0.294 0.2715 17:23:10
Bid Price Ask Price Spread Spread % News
0.3556 0.36 0.0044 1.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
52,488 61,007,625 $ 0.3290066 $ 20,071,911 12,064,836 0.14 - 1.96
Last Trade Time Type Quantity Stock Price Currency
17:26:35 10 $ 0.36 USD

Titan Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.44M 95.66M 92.67M $ 3.61M $ - -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 3.20%

more financials information »

Titan Pharmaceuticals News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TTNP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3040.3790.25970.28016816,096,1780.05618.42%
1 Month0.360.4180.250.297554413,521,4120.000.0%
3 Months0.22990.4180.190.27356288,504,1050.130156.59%
6 Months0.190.5450.150.286765612,741,8280.1789.47%
1 Year1.171.960.140.28109987,693,862-0.81-69.23%
3 Years14.1017.100.140.92090513,662,700-13.74-97.45%
5 Years5.1960.000.141.862,291,101-4.83-93.06%

Titan Pharmaceuticals Description

Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products. The company product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.
Your Recent History
NASDAQ
TTNP
Titan Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200604 21:41:46